These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 10098757

  • 1. Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis.
    Abudu A, Mangham DC, Reynolds GM, Pynsent PB, Tillman RM, Carter SR, Grimer RJ.
    Br J Cancer; 1999 Mar; 79(7-8):1185-9. PubMed ID: 10098757
    [Abstract] [Full Text] [Related]

  • 2. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K, Tochigi N, Shimoda T, Yabe H, Morioka H, Toyama Y, Hosono A, Beppu Y, Kawai A, Hirohashi S, Kondo T.
    Clin Cancer Res; 2009 Apr 15; 15(8):2885-94. PubMed ID: 19351769
    [Abstract] [Full Text] [Related]

  • 3. Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
    Bacci G, Longhi A, Ferrari S, Mercuri M, Barbieri E, Bertoni F, Bacchini P, Picci P.
    Eur J Surg Oncol; 2006 Nov 15; 32(9):974-9. PubMed ID: 16621429
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis.
    Yabe H, Tsukahara T, Kawaguchi S, Wada T, Sato N, Morioka H, Yabe H.
    Oncol Rep; 2008 Jan 15; 19(1):129-34. PubMed ID: 18097586
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.
    Bacci G, Longhi A, Ferrari S, Mercuri M, Versari M, Bertoni F.
    Acta Oncol; 2006 Jan 15; 45(4):469-75. PubMed ID: 16760184
    [Abstract] [Full Text] [Related]

  • 6. Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
    Argon A, Basaran M, Yaman F, Dizdar Y, Sakar B, Camlica H, Bavbek SE, Ozger H, Darendeliler E, Onat H.
    Jpn J Clin Oncol; 2004 Nov 15; 34(11):667-72. PubMed ID: 15613556
    [Abstract] [Full Text] [Related]

  • 7. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].
    Ullmann C, Beck JD, Holter W, Petsch S, Dunst J, Sauer R, Grabenbauer GG.
    Strahlenther Onkol; 2008 Mar 15; 184(3):137-44. PubMed ID: 18330509
    [Abstract] [Full Text] [Related]

  • 8. Prognostic impact of P53 status in Ewing sarcoma.
    de Alava E, Antonescu CR, Panizo A, Leung D, Meyers PA, Huvos AG, Pardo-Mindán FJ, Healey JH, Ladanyi M.
    Cancer; 2000 Aug 15; 89(4):783-92. PubMed ID: 10951341
    [Abstract] [Full Text] [Related]

  • 9. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Grier HE.
    J Clin Oncol; 2004 Jul 15; 22(14):2873-6. PubMed ID: 15254055
    [Abstract] [Full Text] [Related]

  • 10. [Ewing's sarcoma in children--current surgical treatment options, evaluation of our patients].
    Schovanec J, Mrácek J, Havlas V, Trc T.
    Acta Chir Orthop Traumatol Cech; 2004 Jul 15; 71(4):220-7. PubMed ID: 15456100
    [Abstract] [Full Text] [Related]

  • 11. Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
    La TH, Meyers PA, Wexler LH, Alektiar KM, Healey JH, Laquaglia MP, Boland PJ, Wolden SL.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):544-50. PubMed ID: 16198063
    [Abstract] [Full Text] [Related]

  • 12. Ewing's sarcoma of the pelvis. Long-term survival and functional outcome.
    Sucato DJ, Rougraff B, McGrath BE, Sizinski J, Davis M, Papandonatos G, Green D, Szarzanowicz T, Mindell ER.
    Clin Orthop Relat Res; 2000 Apr 01; (373):193-201. PubMed ID: 10810477
    [Abstract] [Full Text] [Related]

  • 13. Ewing's sarcoma and the development of secondary malignancies.
    Fuchs B, Valenzuela RG, Petersen IA, Arndt CA, Sim FH.
    Clin Orthop Relat Res; 2003 Oct 01; (415):82-9. PubMed ID: 14612633
    [Abstract] [Full Text] [Related]

  • 14. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
    Sturla LM, Westwood G, Selby PJ, Lewis IJ, Burchill SA.
    Cancer Res; 2000 Nov 01; 60(21):6160-70. PubMed ID: 11085540
    [Abstract] [Full Text] [Related]

  • 15. A long-term review of the treatment of patients with Ewing's sarcoma in one institution.
    Sluga M, Windhager R, Lang S, Heinzl H, Krepler P, Mittermayer F, Dominkus M, Zoubek A, Kotz R.
    Eur J Surg Oncol; 2001 Sep 01; 27(6):569-73. PubMed ID: 11520091
    [Abstract] [Full Text] [Related]

  • 16. [Ewing's sarcoma of the jaw. The value of multidisciplinary management. Apropos of 4 cases].
    Baude-Brogniez A, Baranzelli MC, Ferri J, Piot B, Demaille MC, Lecomte-Houcke M, Mercier J, Donazzan M.
    Rev Stomatol Chir Maxillofac; 1999 Apr 01; 100(1):34-7. PubMed ID: 10444768
    [Abstract] [Full Text] [Related]

  • 17. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
    Scotlandi K, Manara MC, Strammiello R, Landuzzi L, Benini S, Perdichizzi S, Serra M, Astolfi A, Nicoletti G, Lollini PL, Bertoni F, Nanni P, Picci P.
    J Clin Oncol; 2003 May 15; 21(10):1952-60. PubMed ID: 12743148
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study).
    Oberlin O, Deley MC, Bui BN, Gentet JC, Philip T, Terrier P, Carrie C, Mechinaud F, Schmitt C, Babin-Boillettot A, Michon J, French Society of Paediatric Oncology.
    Br J Cancer; 2001 Nov 30; 85(11):1646-54. PubMed ID: 11742482
    [Abstract] [Full Text] [Related]

  • 19. Current treatment for Ewing's sarcoma.
    Thacker MM, Temple HT, Scully SP.
    Expert Rev Anticancer Ther; 2005 Apr 30; 5(2):319-31. PubMed ID: 15877528
    [Abstract] [Full Text] [Related]

  • 20. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Paulussen M, Craft AW, Lewis I, Hackshaw A, Douglas C, Dunst J, Schuck A, Winkelmann W, Köhler G, Poremba C, Zoubek A, Ladenstein R, van den Berg H, Hunold A, Cassoni A, Spooner D, Grimer R, Whelan J, McTiernan A, Jürgens H, European Intergroup Cooperative Ewing's Sarcoma Study-92.
    J Clin Oncol; 2008 Sep 20; 26(27):4385-93. PubMed ID: 18802150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.